[
  {
    "ts": null,
    "headline": "If I Could Only Buy 2 Dividend Stocks: June's Top Picks For Global Diversification",
    "summary": "If I Could Only Buy 2 Dividend Stocks: June's Top Picks For Global Diversification",
    "url": "https://finnhub.io/api/news?id=f05a704562cca6687674af598ce9829b9c4693850a3325ea4d3999345da08620",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750428000,
      "headline": "If I Could Only Buy 2 Dividend Stocks: June's Top Picks For Global Diversification",
      "id": 135442602,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f05a704562cca6687674af598ce9829b9c4693850a3325ea4d3999345da08620"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Launches VOLT Wrist and Proximal Humerus Plating Systems in the U.S.",
    "summary": "West Chester - Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, announced the launch of the Variable Angle Optimized Locking Technology Distal Radius and VOLT...",
    "url": "https://finnhub.io/api/news?id=6e6039cfa07402e4fb81b80dd49426643310204be67df5e3d9f9341eb369fb78",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750417401,
      "headline": "Johnson & Johnson Launches VOLT Wrist and Proximal Humerus Plating Systems in the U.S.",
      "id": 135433632,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "West Chester - Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, announced the launch of the Variable Angle Optimized Locking Technology Distal Radius and VOLT...",
      "url": "https://finnhub.io/api/news?id=6e6039cfa07402e4fb81b80dd49426643310204be67df5e3d9f9341eb369fb78"
    }
  },
  {
    "ts": null,
    "headline": "IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant",
    "summary": "Pending the European Commission final decision, regimen offers a new standard of care for eligible MCL patients1,2Positive opinion reinforces Phase 3 TRIANGLE study results by the European MCL Network, showing ibrutinib plus chemotherapy delivers significantly improved overall survival without the burden of transplant1,2BEERSE, BELGIUM, June 20, 2025 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Huma",
    "url": "https://finnhub.io/api/news?id=e99fab51dc86b726860bb403fe0284d85dcc8ee485ec57497725242cd40fa631",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750415940,
      "headline": "IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant",
      "id": 135425700,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pending the European Commission final decision, regimen offers a new standard of care for eligible MCL patients1,2Positive opinion reinforces Phase 3 TRIANGLE study results by the European MCL Network, showing ibrutinib plus chemotherapy delivers significantly improved overall survival without the burden of transplant1,2BEERSE, BELGIUM, June 20, 2025 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Huma",
      "url": "https://finnhub.io/api/news?id=e99fab51dc86b726860bb403fe0284d85dcc8ee485ec57497725242cd40fa631"
    }
  },
  {
    "ts": null,
    "headline": "J&J: CMHP green light for Darzalex SC in myeloma",
    "summary": "Janssen-Cilag International announces that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of a new indication for the subcutaneous...",
    "url": "https://finnhub.io/api/news?id=6cd0176e6dcc704ccca2b315feb2034aac328fd2b74de4bc65b35246e819ae9b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750414001,
      "headline": "J&J: CMHP green light for Darzalex SC in myeloma",
      "id": 135429430,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Janssen-Cilag International announces that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of a new indication for the subcutaneous...",
      "url": "https://finnhub.io/api/news?id=6cd0176e6dcc704ccca2b315feb2034aac328fd2b74de4bc65b35246e819ae9b"
    }
  },
  {
    "ts": null,
    "headline": "J&J: CHMP gives positive opinion for Imbruvica in lymphoma",
    "summary": "Janssen-Cilag International, a Johnson & Johnson company, announces that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for the extension...",
    "url": "https://finnhub.io/api/news?id=ef3f89718b89a840ff22d309c267bb3748e4bbb21f6b91c679f9a3c0d7c81532",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750412904,
      "headline": "J&J: CHMP gives positive opinion for Imbruvica in lymphoma",
      "id": 135428084,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Janssen-Cilag International, a Johnson & Johnson company, announces that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for the extension...",
      "url": "https://finnhub.io/api/news?id=ef3f89718b89a840ff22d309c267bb3748e4bbb21f6b91c679f9a3c0d7c81532"
    }
  },
  {
    "ts": null,
    "headline": "The Retirement Pyramid: The Near-Perfect Blueprint For Maximum Income And Minimum Stress",
    "summary": "The Retirement Pyramid: The Near-Perfect Blueprint For Maximum Income And Minimum Stress",
    "url": "https://finnhub.io/api/news?id=128c04651eef7acf30c8172f40819a7b63b6ad270bb02f4418868c4ab550977b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750404600,
      "headline": "The Retirement Pyramid: The Near-Perfect Blueprint For Maximum Income And Minimum Stress",
      "id": 135424141,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=128c04651eef7acf30c8172f40819a7b63b6ad270bb02f4418868c4ab550977b"
    }
  }
]